United States · FDA National Drug Code directory
NEMLUVIO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0299-6220_df0e2be2-b6bd-40e5-9175-0c8e893433ea
- Product NDC
- 0299-6220
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- nemolizumab-ilto
- Labeler
- Galderma Laboratories, L.P.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20240813
- Source listing expiry
- 20261231
Source-listed ingredients
- NEMOLIZUMAB — 30 mg/100mg
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (0299-6220-10) / 30 mg in 1 SYRINGE, GLASS · 0299-6220-10
- 1 SYRINGE in 1 CARTON (0299-6220-15) / 30 mg in 1 SYRINGE · 0299-6220-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →